Pages that link to "Q38624678"
Jump to navigation
Jump to search
The following pages link to Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium (Q38624678):
Displaying 31 items.
- Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease (Q26996385) (← links)
- CREB trans-activation of disruptor of telomeric silencing-1 mediates forskolin inhibition of CTGF transcription in mesangial cells (Q33727860) (← links)
- The physiological impact of the serum and glucocorticoid-inducible kinase SGK1 (Q33904863) (← links)
- The Role of SIRT1 in Diabetic Kidney Disease. (Q34312543) (← links)
- Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways. (Q35120420) (← links)
- Aldosterone-Induced Fibrosis in the Kidney: Questions and Controversies (Q36688855) (← links)
- Aldosterone activates NF-kappaB in the collecting duct. (Q37042182) (← links)
- Aldosterone: effects on the kidney and cardiovascular system (Q37710377) (← links)
- Pathophysiological Roles of Aldosterone and Mineralocorticoid Receptor in the Kidney (Q37824130) (← links)
- Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1 (Q37951353) (← links)
- Therapeutic potential of serum and glucocorticoid inducible kinase inhibition (Q38090700) (← links)
- Mineralocorticoid receptor activation as an etiological factor in kidney diseases (Q38119861) (← links)
- Sodium chloride, SGK1, and Th17 activation (Q38282527) (← links)
- Alterations in the long non‑coding RNA transcriptome in mesangial cells treated with aldosterone in vitro (Q38429331) (← links)
- Effects of propolis, caffeic acid phenethyl ester, and pollen on renal injury in hypertensive rat: An experimental and theoretical approach (Q38612239) (← links)
- Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation (Q41896485) (← links)
- Effect of eplerenone, a selective aldosterone blocker, on the development of diabetic nephropathy in type 2 diabetic rats (Q41970822) (← links)
- PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy (Q42672479) (← links)
- Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11β-HSD activity (Q43143831) (← links)
- The role of Na -H exchanger isoform 1 in aldosterone-induced glomerulosclerosis in vivo (Q43265101) (← links)
- Going with the Wnt? Focus on "Hyperaldosteronism, hypervolemia, and increased blood pressure in mice expressing defective APC". (Q45954140) (← links)
- Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats. (Q45964954) (← links)
- Spironolactone ameliorates transplant vasculopathy in renal chronic transplant dysfunction in rats (Q46108426) (← links)
- Association of aldosterone synthase (CYP11B2) gene -344T/C polymorphism with the risk of primary chronic glomerulonephritis in the Polish population. (Q50987680) (← links)
- Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification. (Q53357907) (← links)
- Impact of aldosterone synthase gene C-344T polymorphism on IgA nephropathy. (Q54378865) (← links)
- Local Mineralocorticoid Receptor Activation and the Role of Rac1 in Obesity-Related Diabetic Kidney Disease (Q58051415) (← links)
- Aldosterone-induced kidney injury is mediated by NFκB activation (Q82436795) (← links)
- The kidney and hypertension (Q83476697) (← links)
- Serum- and glucocorticoid-inducible kinase 1 and the response to cell stress (Q92932383) (← links)
- Role of mineralocorticoid receptor antagonists in kidney diseases (Q101578601) (← links)